Detalhe da pesquisa
1.
Toripalimab, a therapeutic monoclonal anti-PD-1 antibody with high binding affinity to PD-1 and enhanced potency to activate human T cells.
Cancer Immunol Immunother
; 73(3): 60, 2024 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38400933